WO2011099812A3 - 감초 추출물을 포함하는 로타바이러스 감염의 예방 또는 치료용 조성물 - Google Patents

감초 추출물을 포함하는 로타바이러스 감염의 예방 또는 치료용 조성물 Download PDF

Info

Publication number
WO2011099812A3
WO2011099812A3 PCT/KR2011/000940 KR2011000940W WO2011099812A3 WO 2011099812 A3 WO2011099812 A3 WO 2011099812A3 KR 2011000940 W KR2011000940 W KR 2011000940W WO 2011099812 A3 WO2011099812 A3 WO 2011099812A3
Authority
WO
WIPO (PCT)
Prior art keywords
extract
preventing
composition
rotavirus infection
licorice extract
Prior art date
Application number
PCT/KR2011/000940
Other languages
English (en)
French (fr)
Other versions
WO2011099812A2 (ko
Inventor
이우송
노문철
류영배
박수진
장종선
권형준
김하현
정형재
Original Assignee
한국생명공학연구원
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 한국생명공학연구원 filed Critical 한국생명공학연구원
Priority to US13/578,528 priority Critical patent/US20130041023A1/en
Priority to CN2011800176253A priority patent/CN102821772A/zh
Priority to EP11742504.1A priority patent/EP2535056A4/en
Publication of WO2011099812A2 publication Critical patent/WO2011099812A2/ko
Publication of WO2011099812A3 publication Critical patent/WO2011099812A3/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484—Glycyrrhiza (licorice)
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
    • A23L7/10—Cereal-derived products
    • A23L7/198—Dry unshaped finely divided cereal products, not provided for in groups A23L7/117 - A23L7/196 and A23L29/00, e.g. meal, flour, powder, dried cereal creams or extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Nutrition Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Food Science & Technology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

본 발명은 감초 추출물, 이의 분획물 또는 이로부터 분리한 화합물을 포함하는 로타바이러스 감염의 예방 또는 치료용 조성물에 관한 것으로, 감초 추출물, 이의 분획물 또는 이로부터 분리한 화합물이 항로타바이러스의 효과를 가지고, 다양한 로타바이러스에 대해 살바이러스 및 세포변성 억제 효과를 동시에 나타내므로 로타바이러스 감염의 예방 또는 치료에 유용하게 사용될 수 있다.
PCT/KR2011/000940 2010-02-12 2011-02-11 감초 추출물을 포함하는 로타바이러스 감염의 예방 또는 치료용 조성물 WO2011099812A2 (ko)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US13/578,528 US20130041023A1 (en) 2010-02-12 2011-02-11 Composition for Preventing or Treating Rotavirus Infection Comprising Licorice Extract
CN2011800176253A CN102821772A (zh) 2010-02-12 2011-02-11 包含甘草提取物的用于预防或治疗轮状病毒感染的组合物
EP11742504.1A EP2535056A4 (en) 2010-02-12 2011-02-11 COMPOSITION FOR PREVENTING OR TREATING ROTAVIRUS INFECTION CONTAINING A LICORICE EXTRACT

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020100013543A KR101138461B1 (ko) 2010-02-12 2010-02-12 감초 추출물을 포함하는 로타바이러스 감염의 예방 또는 치료용 조성물
KR10-2010-0013543 2010-02-12

Publications (2)

Publication Number Publication Date
WO2011099812A2 WO2011099812A2 (ko) 2011-08-18
WO2011099812A3 true WO2011099812A3 (ko) 2011-12-29

Family

ID=44368327

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2011/000940 WO2011099812A2 (ko) 2010-02-12 2011-02-11 감초 추출물을 포함하는 로타바이러스 감염의 예방 또는 치료용 조성물

Country Status (5)

Country Link
US (1) US20130041023A1 (ko)
EP (1) EP2535056A4 (ko)
KR (1) KR101138461B1 (ko)
CN (1) CN102821772A (ko)
WO (1) WO2011099812A2 (ko)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103054954A (zh) * 2012-12-28 2013-04-24 青岛爱维互动信息技术有限公司 一种感冒中药组成
KR101866742B1 (ko) * 2015-11-19 2018-06-12 대봉엘에스 주식회사 Nrf-2 활성증진 감초 추출물의 제조방법, 및 이를 함유하는 화장료 조성물
CN111084772A (zh) * 2019-12-30 2020-05-01 李世� 一种粗毛甘草素c的医药新用途
CA3234285A1 (en) * 2021-10-07 2023-04-13 Matregenix, Inc. Electrospun nanofibrous polymer membrane for use in air filtration applications
CN115192556B (zh) * 2022-05-06 2023-06-16 黑龙江八一农垦大学 异甘草素在制备抗猪流行性腹泻病毒的药物中的应用

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20030095540A (ko) * 2002-06-12 2003-12-24 주식회사 뉴로넥스 감초, 강황 및 소엽의 추출물을 함유한 위염 및 위궤양의예방 및 치료를 위한 조성물
US20080152735A1 (en) * 2006-12-25 2008-06-26 National Defense Medical Center Herbal Extract Having Anti- Influenza Virus Activity and Preparation of Same
KR20080106789A (ko) * 2007-06-04 2008-12-09 대한민국(관리부서 : 농림부 국립수의과학검역원) 동물의 면역능을 증강시키는 감초 추출물 및 그 제조 방법
KR20090016883A (ko) * 2007-08-13 2009-02-18 경남대학교 산학협력단 감초 추출물을 유효성분으로 함유하는 퇴행성 신경질환예방 및 치료용 조성물
KR20090075481A (ko) * 2008-01-04 2009-07-08 한림대학교 산학협력단 감초 추출물을 포함하는 항산화 조성물
KR20090092039A (ko) * 2008-02-26 2009-08-31 인하대학교 산학협력단 역상 액체 크로마토그래피를 이용하여 감초로부터유용성분을 분리하는 추출방법

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01175942A (ja) * 1987-12-28 1989-07-12 Sanyo Kokusaku Pulp Co Ltd 抗ウイルス性医薬用組成物
KR100355490B1 (ko) * 1999-10-13 2002-10-09 주식회사태창물산 로타바이러스에 대해 감염 억제활성을 갖는 지각 추출물
EP1401458B1 (en) * 2000-03-09 2011-01-12 Yale University Composition consisting of phy906 and chemotherapeutic agents
CN1377674A (zh) * 2001-04-04 2002-11-06 陕西师范大学 治疗小儿腹泻的中药冲剂
KR100516194B1 (ko) * 2002-12-27 2005-09-21 김성호 항종양활성을 갖는 생약 추출물
KR100601823B1 (ko) * 2004-02-27 2006-07-19 김용욱 인간 면역 결핍 바이러스에 감염된 환자의 면역기능을 증강시키는 생약추출 조성물
EP2065049A4 (en) 2006-09-07 2010-01-13 Shirong Lou USE OF SOLIDAGO VIRGAUREA IN THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT AND PREVENTION OF A VIRUS
JP5334448B2 (ja) * 2008-05-09 2013-11-06 丸善製薬株式会社 グルタチオン産生促進剤およびグルタチオンの欠乏に起因する疾患の予防・治療剤
CN101273778A (zh) * 2008-05-13 2008-10-01 罗海滨 金银花凉茶及其制备方法
CN101474330B (zh) * 2009-01-19 2011-04-13 河南天方药业中药有限公司 一种止泻口服液及其制备工艺

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20030095540A (ko) * 2002-06-12 2003-12-24 주식회사 뉴로넥스 감초, 강황 및 소엽의 추출물을 함유한 위염 및 위궤양의예방 및 치료를 위한 조성물
US20080152735A1 (en) * 2006-12-25 2008-06-26 National Defense Medical Center Herbal Extract Having Anti- Influenza Virus Activity and Preparation of Same
KR20080106789A (ko) * 2007-06-04 2008-12-09 대한민국(관리부서 : 농림부 국립수의과학검역원) 동물의 면역능을 증강시키는 감초 추출물 및 그 제조 방법
KR20090016883A (ko) * 2007-08-13 2009-02-18 경남대학교 산학협력단 감초 추출물을 유효성분으로 함유하는 퇴행성 신경질환예방 및 치료용 조성물
KR20090075481A (ko) * 2008-01-04 2009-07-08 한림대학교 산학협력단 감초 추출물을 포함하는 항산화 조성물
KR20090092039A (ko) * 2008-02-26 2009-08-31 인하대학교 산학협력단 역상 액체 크로마토그래피를 이용하여 감초로부터유용성분을 분리하는 추출방법

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
SONG, JIN UG ET AL.: "Effect of Glycyrrhetinic Acid on MA-104 Cell Infected with Bovine Rotavirus", 1999 SYMPOSIUM OF KOSFA AND 24TH FALL CONFERENCE PRESENTATION MATERIALS, 21 October 1999 (1999-10-21), pages 89 *

Also Published As

Publication number Publication date
KR101138461B1 (ko) 2012-04-26
KR20110093474A (ko) 2011-08-18
US20130041023A1 (en) 2013-02-14
CN102821772A (zh) 2012-12-12
EP2535056A2 (en) 2012-12-19
WO2011099812A2 (ko) 2011-08-18
EP2535056A4 (en) 2013-10-02

Similar Documents

Publication Publication Date Title
WO2014159628A3 (en) Preventing or delaying chill injury response in plants
PL2941263T3 (pl) Oczyszczony wyciąg wyizolowany z pseudolysimachion rotundum var. subintegrum zawierający liczne składniki czynne, wytwarzanie tego ekstraktu i kompozycja zawierająca ekstrakt jako składnik czynny do zapobiegania lub leczenia zapalenia, alergii i astmy
WO2012077077A8 (en) Fungicidal mixtures
WO2012050396A3 (ko) 생약 추출물을 포함하는 간암 예방 또는 치료용 약학적 조성물
EP3067059A4 (en) Pharmaceutical composition for preventing or treating thyroid diseases, containing lonicera caerulea l. var. edulis fruit extract as active ingredient
WO2012071520A3 (en) Fungicidal compositions and methods
WO2011099812A3 (ko) 감초 추출물을 포함하는 로타바이러스 감염의 예방 또는 치료용 조성물
EP3348254A4 (en) COMPOSITION TO TREAT SKIN INSPECTION THROUGH HYDROTH AND FINE PARTICLES WITH NATURAL PLANT EXTRACT
WO2014047653A3 (en) Methods and compositions for extending shelf life of plant products
WO2011150457A3 (en) Haematopoietic-prostaglandin d2 synthase inhibitors
WO2012050398A3 (ko) 생약 추출물을 포함하는 폐암 예방 또는 치료용 약학적 조성물
WO2012134169A3 (ko) 조각인 추출물을 포함하는 폐암 치료용 조성물 및 건강 기능성 식품
EP3295946A4 (en) Composition, containing lithospermi radix extract as active ingredient, for preventing, alleviating, or treating peripheral neuropathy
WO2009011910A3 (en) Imidazolidinone compounds, methods to inhibit deubiquitination and methods of treatment
WO2012024394A3 (en) Compositions comprising paulownin and/or paulownia extracts and uses thereof
WO2011067209A3 (en) Pesticidal mixtures
WO2016093554A3 (ko) 신규한 4-(아릴)-n-(2-알콕시티에노[3,2-b]피라진-3-일)-피페라진-1-카복스아미드 유도체 및 이의 항증식 효과
WO2014136059A3 (en) Prodrugs of multifunctional nitroxide derivatives and uses thereof
WO2012134172A3 (ko) 오미자 에틸아세테이트 분획물 또는 이로부터 분리한 우웨이지수 ｃ를 유효성분으로 포함하는 비만 예방 또는 치료용 조성물
WO2019098811A3 (ko) Chp(시클로-히스프로)를 포함하는 골 손실 질환의 예방, 개선 또는 치료용 조성물
EP3144005A4 (en) Composition for preventing and treating male infertility, containing mixed herbal extract as active ingredient and use thereof
WO2014133811A3 (en) Compounds from invasive salvinias and methods of using the same
WO2012134252A3 (ko) 마자인 추출물을 포함하는 신장암 치료용 조성물 및 건강 기능성 식품
WO2014001729A3 (fr) Compositions pour application topique comprenant un extrait naturel de plante
WO2013081420A3 (ko) 페녹시프로판올 유도체 및 이를 함유하는 약학적 조성물

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 201180017625.3

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11742504

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2011742504

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 13578528

Country of ref document: US